Could FDA reform hurt the medical device industry? In a Q&A with the Minneapolis Star Tribune, Mark DuVal, president of DuVal & Associates P.A. (Minneapolis), suggests just that. His main concern was the 510(k) process. DuVal says that the 510(k) process works well because it gives FDA the flexibility to request more information about products from companies while keeping innovation alive.